Germany
Japan
United Kingdom
China
USD 1,430.00
3 Weeks
Lenti ORF particles, GRIN1 (Myc-DDK-tagged)-Human glutamate receptor, ionotropic, N-methyl D-aspartate 1 (GRIN1), transcript variant NR1-4, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
- LentiORF®
-
Lentiviral Particles
DownloadUSD 1,520.00
3 Weeks
Lenti ORF particles, TERT (Myc-DDK-tagged)-Human telomerase reverse transcriptase (TERT), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
- LentiORF®
-
Lenti ORF particles, ABCC10 (Myc-DDK tagged) - Human ATP-binding cassette, sub-family C (CFTR/MRP), member 10 (ABCC10), transcript variant MRP7, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
- LentiORF®
-
USD 1,420.00
6 Weeks
Lenti ORF particles, Human androgen receptor (AR), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
- LentiORF®
-
Lenti ORF particles, PDCD1 (Myc-DDK tagged) - Human programmed cell death 1 (PDCD1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 2,220.00
3 Weeks
Lenti ORF particles, ERBB2 (Myc-DDK tagged) - Human v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) (ERBB2), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, MYLIP (Myc-DDK tagged) - Human myosin regulatory light chain interacting protein (MYLIP), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, CELSR2 (Myc-DDK tagged) - Human cadherin, EGF LAG seven-pass G-type receptor 2 (flamingo homolog, Drosophila) (CELSR2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 2,964.00
2 Weeks
Lenti ORF particles, SCN5A (Myc-DDK tagged) - Human sodium channel, voltage-gated, type V, alpha subunit (SCN5A), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,500.00
3 Weeks
Lenti ORF particles, SARM1 (Myc-DDK-tagged)-Human sterile alpha and TIR motif containing 1 (SARM1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,704.00
3 Weeks
Lenti ORF particles, CDH1 (Myc-DDK-tagged)-Human cadherin 1, type 1, E-cadherin (epithelial) (CDH1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, CEACAM1 (Myc-DDK-tagged)-Human carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) (CEACAM1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, ENPP1 (Myc-DDK tagged) - Human ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,092.00
3 Weeks
Lenti ORF particles, NR4A2 (Myc-DDK-tagged)-Human nuclear receptor subfamily 4, group A, member 2 (NR4A2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, IL2 (Myc-DDK tagged) - Human interleukin 2 (IL2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, TCF7 (Myc-DDK-tagged)-Human transcription factor 7 (T-cell specific, HMG-box) (TCF7), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,560.00
3 Weeks
Lenti ORF particles, MAPT (Myc-DDK-tagged)-Human microtubule-associated protein tau (MAPT), transcript variant 6, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, CD33 (Myc-DDK tagged) - Human CD33 molecule (CD33), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, MYCN (Myc-DDK tagged) - Human v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) (MYCN), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, SORT1 (Myc-DDK-tagged)-Human sortilin 1 (SORT1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, SOX4 (Myc-DDK-tagged)-Human SRY (sex determining region Y)-box 4 (SOX4), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, DLL4 (Myc-DDK tagged) - Human delta-like 4 (Drosophila) (DLL4), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, TWIST1 (Myc-DDK tagged) - Human twist homolog 1 (Drosophila) (TWIST1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, HSD17B1 (Myc-DDK-tagged)-Human hydroxysteroid (17-beta) dehydrogenase 1 (HSD17B1), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,020.00
3 Weeks
Lenti ORF particles, TH (Myc-DDK tagged) - Human tyrosine hydroxylase (TH), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, CACNA1A (Myc-DDK tagged) - Human calcium channel, voltage-dependent, P/Q type, alpha 1A subunit (CACNA1A), transcript variant 2, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,092.00
3 Weeks
Lenti ORF particles, TNFRSF8 (Myc-DDK-tagged)-Human tumor necrosis factor receptor superfamily, member 8 (TNFRSF8), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
USD 1,248.00
3 Weeks
Lenti ORF particles, TSHR (Myc-DDK tagged) - Human thyroid stimulating hormone receptor (TSHR), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, IL1RL2 (Myc-DDK tagged) - Human interleukin 1 receptor-like 2 (IL1RL2), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, TMEM158 (Myc-DDK tagged) - Human transmembrane protein 158 (gene/pseudogene) (TMEM158), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
-
Lenti ORF particles, M6PR (Myc-DDK tagged) - Human mannose-6-phosphate receptor (cation dependent) (M6PR), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
- LentiORF®
-
Lenti ORF particles, MYC (Myc-DDK tagged) - Human v-myc myelocytomatosis viral oncogene homolog (avian) (MYC), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
- LentiORF®
-
Lenti ORF particles, CD81 (Myc-DDK tagged) - Human CD81 molecule (CD81), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
- LentiORF®
-
Lenti ORF particles, TRPV1 (Myc-DDK tagged) - Human transient receptor potential cation channel, subfamily V, member 1 (TRPV1), transcript variant 1, 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
- LentiORF®
-
Active filters
Category
- cDNA Clones
Species
- Human
Vectors
- pLenti-C-Myc-DDK
Families
- Druggable Genome
Filter by
Target Symbol
- VEGFA (7)
- AGTR1 (5)
- BDNF (5)
- CD46 (5)
- FGFR1 (5)
- HNF4A (5)
- MITF (5)
- NR1I3 (5)
- TP63 (5)
- APP (4)
- AURKA (4)
- BAG6 (4)
- CASP1 (4)
- CD44 (4)
- CREM (4)
- EYA1 (4)
- LDLRAD4 (4)
- MAPK8 (4)
- MAPT (4)
- MUC1 (4)
- NCOA4 (4)
- NFATC1 (4)
- NRG1 (4)
- NTRK2 (4)
- POSTN (4)
- SEZ6L2 (4)
- SNCA (4)
- TMPRSS4 (4)
- ABL2 (3)
- ADAR (3)
- AKR1C2 (3)
- ALDH1A2 (3)
- ALDH3A1 (3)
- ANXA2 (3)
- APEX1 (3)
- AR (3)
- ARTN (3)
- ASAH1 (3)
- ASGR2 (3)
- BAIAP2 (3)
- BAX (3)
- BCL2L14 (3)
- BMP1 (3)
- BMP4 (3)
- CAMK2G (3)
- CASP8 (3)
- CCR2 (3)
- CD22 (3)
- CDKN2A (3)
- CEACAM1 (3)
- CKMT2 (3)
- CLEC2D (3)
- DCLK1 (3)
- DDR1 (3)
- DIO2 (3)
- ERCC1 (3)
- ERG (3)
- ETS1 (3)
- FBXO44 (3)
- FBXW11 (3)
- FBXW7 (3)
- FGF8 (3)
- FGR (3)
- FXYD2 (3)
- FYN (3)
- GATA2 (3)
- GBA (3)
- GCK (3)
- GDNF (3)
- GLRA2 (3)
- GNAS (3)
- GPR17 (3)
- GPX4 (3)
- GRIN1 (3)
- HCK (3)
- HNRNPD (3)
- HRAS (3)
- IFNAR2 (3)
- IGF1 (3)
- IGF2 (3)
- IKBKG (3)
- IL1RN (3)
- IRAK1 (3)
- ITGB1 (3)
- KAT5 (3)
- KLC2 (3)
- KLK12 (3)
- KLK5 (3)
- KLK6 (3)
- KREMEN1 (3)
- LANCL1 (3)
- LPAR6 (3)
- LSR (3)
- MAPK14 (3)
- MAPK9 (3)
- MDH1 (3)
- MECOM (3)
- MSLN (3)
- NCR1 (3)
- NCR3 (3)
Lentivirus
Tags
Mutants
Mammalian Cell Selection
Pathways
- Metabolic pathways (415)
- Pathways in cancer (372)
- MAPK signaling pathway (283)
- Cytokine-cytokine receptor interaction (264)
- Neuroactive ligand-receptor interaction (255)
- Focal adhesion (191)
- Chemokine signaling pathway (187)
- Regulation of actin cytoskeleton (180)
- Neurotrophin signaling pathway (162)
- Calcium signaling pathway (159)
- Jak-STAT signaling pathway (150)
- Wnt signaling pathway (145)
- Insulin signaling pathway (133)
- Natural killer cell mediated cytotoxicity (131)
- T cell receptor signaling pathway (131)
- Toll-like receptor signaling pathway (127)
- ErbB signaling pathway (118)
- Progesterone-mediated oocyte maturation (117)
- Endocytosis (113)
- Colorectal cancer (112)
- Prostate cancer (112)
- Axon guidance (111)
- Apoptosis (110)
- Pancreatic cancer (106)
- GnRH signaling pathway (104)
- Oocyte meiosis (103)
- Cell cycle (101)
- Leukocyte transendothelial migration (99)
- Alzheimer's disease (96)
- Chronic myeloid leukemia (95)
- B cell receptor signaling pathway (94)
- Melanogenesis (94)
- Vascular smooth muscle contraction (92)
- Small cell lung cancer (91)
- VEGF signaling pathway (91)
- Gap junction (90)
- Cell adhesion molecules (CAMs) (89)
- Adherens junction (88)
- Fc epsilon RI signaling pathway (88)
- Renal cell carcinoma (88)
- Melanoma (87)
- TGF-beta signaling pathway (86)
- Ubiquitin mediated proteolysis (86)
- Hematopoietic cell lineage (85)
- Glioma (81)
- NOD-like receptor signaling pathway (78)
- Adipocytokine signaling pathway (77)
- Tight junction (77)
- Acute myeloid leukemia (75)
- Fc gamma R-mediated phagocytosis (75)
- Long-term potentiation (75)
- Dilated cardiomyopathy (74)
- Non-small cell lung cancer (73)
- Purine metabolism (73)
- RIG-I-like receptor signaling pathway (72)
- Huntington's disease (71)
- p53 signaling pathway (71)
- Endometrial cancer (70)
- Hypertrophic cardiomyopathy (HCM) (69)
- Long-term depression (66)
- Type II diabetes mellitus (65)
- Amyotrophic lateral sclerosis (ALS) (63)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (59)
- Bladder cancer (59)
- Epithelial cell signaling in Helicobacter pylori infection (59)
- Complement and coagulation cascades (58)
- Lysosome (58)
- ECM-receptor interaction (54)
- mTOR signaling pathway (53)
- Hedgehog signaling pathway (47)
- Phosphatidylinositol signaling system (46)
- Basal cell carcinoma (45)
- Glycolysis / Gluconeogenesis (44)
- Pathogenic Escherichia coli infection (43)
- Cytosolic DNA-sensing pathway (41)
- PPAR signaling pathway (41)
- Parkinson's disease (40)
- Thyroid cancer (40)
- Viral myocarditis (38)
- ABC transporters (35)
- Antigen processing and presentation (35)
- Arginine and proline metabolism (35)
- Primary immunodeficiency (35)
- Metabolism of xenobiotics by cytochrome P450 (34)
- Retinol metabolism (34)
- Cardiac muscle contraction (33)
- Olfactory transduction (33)
- Lysine degradation (32)
- Nucleotide excision repair (32)
- Autoimmune thyroid disease (31)
- Drug metabolism - cytochrome P450 (30)
- Arachidonic acid metabolism (29)
- Vibrio cholerae infection (29)
- Inositol phosphate metabolism (28)
- Notch signaling pathway (28)
- Valine (28)
- Prion diseases (27)
- Pyrimidine metabolism (27)
- Pyruvate metabolism (27)
- Base excision repair (26)
- Regulation of autophagy (26)
- Taste transduction (26)
- Tyrosine metabolism (26)
- Drug metabolism - other enzymes (25)
- Systemic lupus erythematosus (25)
- leucine and isoleucine degradation (25)
- Maturity onset diabetes of the young (24)
- Starch and sucrose metabolism (24)
- Tryptophan metabolism (24)
- Fructose and mannose metabolism (23)
- Type I diabetes mellitus (23)
- Galactose metabolism (22)
- Glutathione metabolism (21)
- Glycerophospholipid metabolism (21)
- Sphingolipid metabolism (21)
- Amino sugar and nucleotide sugar metabolism (20)
- Cysteine and methionine metabolism (20)
- Androgen and estrogen metabolism (19)
- Dorso-ventral axis formation (19)
- Fatty acid metabolism (19)
- Glycerolipid metabolism (19)
- Propanoate metabolism (19)
- Allograft rejection (18)
- Citrate cycle (TCA cycle) (18)
- Homologous recombination (18)
- Linoleic acid metabolism (17)
- Renin-angiotensin system (17)
- Spliceosome (17)
- Histidine metabolism (15)
- Mismatch repair (15)
- Nitrogen metabolism (15)
- Oxidative phosphorylation (15)
- Alanine (14)
- Butanoate metabolism (14)
- Ether lipid metabolism (14)
- Graft-versus-host disease (14)
- Pentose phosphate pathway (14)
- Phenylalanine metabolism (14)
- Proteasome (14)
- SNARE interactions in vesicular transport (14)
- aspartate and glutamate metabolism (14)
- Circadian rhythm - mammal (13)
- Glycosaminoglycan degradation (13)
- DNA replication (12)
- Glycine (12)
- Non-homologous end-joining (12)
- Porphyrin and chlorophyll metabolism (12)
- Ribosome (12)
- serine and threonine metabolism (12)
- beta-Alanine metabolism (11)
- C21-Steroid hormone metabolism (10)
- Riboflavin metabolism (10)
- Asthma (9)
- Other glycan degradation (9)
- Primary bile acid biosynthesis (9)
- Steroid biosynthesis (9)
- Aminoacyl-tRNA biosynthesis (8)
- Folate biosynthesis (8)
- N-Glycan biosynthesis (8)
- Ascorbate and aldarate metabolism (7)
- Basal transcription factors (7)
- Glycosphingolipid biosynthesis - globo series (7)
- Terpenoid backbone biosynthesis (7)
- alpha-Linolenic acid metabolism (7)
- Glyoxylate and dicarboxylate metabolism (6)
- Limonene and pinene degradation (6)
- Nicotinate and nicotinamide metabolism (6)
- Pantothenate and CoA biosynthesis (6)
- Pentose and glucuronate interconversions (6)
- leucine and isoleucine biosynthesis (6)
- Glycosphingolipid biosynthesis - lacto and neolacto series (5)
- One carbon pool by folate (5)
- RNA degradation (5)
- Selenoamino acid metabolism (5)
- Biosynthesis of unsaturated fatty acids (4)
- Glycosphingolipid biosynthesis - ganglio series (4)
- Methane metabolism (4)
- Thiamine metabolism (4)
- Caffeine metabolism (3)
- Fatty acid biosynthesis (3)
- Glycosylphosphatidylinositol(GPI)-anchor biosynthesis (3)
- Protein export (3)
- Taurine and hypotaurine metabolism (3)
- Fatty acid elongation in mitochondria (2)
- Heparan sulfate biosynthesis (2)
- O-Glycan biosynthesis (2)
- Synthesis and degradation of ketone bodies (2)
- Ubiquinone and other terpenoid-quinone biosynthesis (2)
- Vitamin B6 metabolism (2)
- D-Arginine and D-ornithine metabolism (1)
- D-Glutamine and D-glutamate metabolism (1)
- Keratan sulfate biosynthesis (1)
- Phenylalanine (1)
- Sulfur metabolism (1)
- tyrosine and tryptophan biosynthesis (1)